Abivax stock skyrocketed in July after the company announced overwhelmingly positive topline results from its Phase 3 ...
An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...
Zacks Investment Research on MSN
LLY trading above 50 & 200-day SMAs for 2 months: How to play the stock
Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
UpSMART, a research programme involving 24 European cancer centres, aimed to promote digital innovation in early-phase clinical research addressing challenges in recruitment, data collection and ...
Eli Drinkwitz walked to the lectern in the defensive line meeting room inside the Missouri football south end zone facility. Diet Coke in hand. A fresh Mizzou-emblazoned quarter zip. Oval-Tiger ...
LillyDirect is a legitimate, direct-to-consumer platform that offers authentic Eli Lilly medication. This platform accepts insurance and offers self-pay options. LillyDirect is partnered with licensed ...
ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...
Zacks Investment Research on MSN
Lilly Crosses $1 Trillion Market Cap: Here's What Is Driving the Rally
Eli Lilly LLY secured a significant milestone on Friday when it became the first company in the healthcare space to reach $1 trillion in market value. With this breakthrough, Lilly is now the second ...
An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...
Eli Lilly and Novo Nordisk are collaborating with Waltz Health to launch direct-to-employer access for obesity management medications. Waltz Health gave no information on the prices of GLP-1 drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results